Received Jun 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | W017539 | — |
No additional AE.; Inbound call from HCP calling to report administration of GARDASIL-9 that was expired. Caller states that the first dose of the series was administered to a 14 year old male on 3-JUN-2025. Caller reports that the dose administered on 4-JAN-2025. C; Information has been received from a Medical Assistant and refers to a 14-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 03-Jun-2025, the first dose of the series of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (0.5 mL once, lot #W017539, expiration date: 04-Jan-2025; strength and route were not provided) was administered to the patient for prophylaxis (expired vaccine used). It was also reported that the dose administered on 04-Jan-2025. No symptomatic adverse events reported. No additional AE. No additional information at that time.